Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis
Research output: Contribution to journal › Article › peer-review
Authors
Colleges, School and Institutes
Abstract
Anti-CCP antibodies are very specific for the development of RA in patients with very early synovitis.[1] Their predictive value is underscored by their high weighting in an algorithm validated in patients with undifferentiated synovitis
Details
| Original language | English |
|---|---|
| Pages (from-to) | 627-628 |
| Number of pages | 2 |
| Journal | Annals of the Rheumatic Diseases |
| Volume | 69 |
| Issue number | 3 |
| Publication status | Published - 20 Oct 2009 |